Salix Pharmaceuticals develops drugs and medical devices that prevents and treats various gastrointestinal disorders.
Business Model:
Revenue: $1B
Employees: 501-1,000
Salix Pharmaceuticals was acquired by
Bausch Health.
The acquisition happend on 2015-02-22.
Details of the transaction were not public
Address: 400 Somerset Corporate Boulevard
City: Bridgewater
State: NJ
Zip: 08807
Country: US
Salix Pharmaceuticals develops drugs and medical devices that prevents and treats various gastrointestinal disorders.
Contact Phone:
+18003214576
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
11/20/2000
Ticker Symbol:
SLXP
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
1/2013 | Atlantic Healthcare | Series A | 0 |
11/2016 | Atlantic Healthcare | Series B | 0 |
11/2016 | Atlantic Healthcare | Series B | 0 |
1/2013 | Atlantic Healthcare | Series A | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2008 | Debt | $60M | 12/2013 | Post-IPO Equity | $750M |
---|
Announced Date | Name | Price |
---|---|---|
11/2013 | Santarus | |
11/2011 | Oceana Therapeutics |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|